Latest Breaking News On - Vanguard diagnostics pvt ltd - Page 1 : comparemela.com
Enzyme Linked Immunosorbent Assay Market To Reflect Tremendous Growth Potential With A CAGR Of 5 1% by 2030 | Shenzhen YHLO Biotech Co , Ltd , R&D Systems, Biomerieux S A , Bio-Rad Laboratories, Inc |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
10,000 Sachets Of DRDO-Developed Anti-COVID Drug 2-DG Are Now Available In The Market
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Loading the player.
Singapore social media outlets issue correction notice on COVID-19 variant following Kejriwal s remarks
Facebook and Twitter along with Singapore s largest media house have complied with the government s directive to issue a correction to the users of social media platforms in the city-state after Delhi Chief Minister Arvind Kejriwal tweeted about a new COVID-19 Singapore variant . Singapore s Ministry of Health on Thursday invoked the Protection from Online Falsehoods and Manipulation Act (Pofma) in response to a statement circulating online claiming that there is a new variant of COVID-19 which originated in the city-state that is more harmful to children. Kejriwal on Tuesday wrote on Twitter claiming that the new strain of the coronavirus found in Singapore could be very dangerous for children and urged the Indian government to cancel all air links with Singapore.
May 22, 2021 Share
Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit ‘DIPCOVAN’, the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance. The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent. The kit has been developed in association with Vanguard Diagnostics Pvt Ltd, a development and manufacturing diagnostics company based at New Delhi.
DIPCOVAN is intended for the qualitative detection of IgG antibodies in human serum or plasma, targeting SARS-CoV-2 related antigens. It offers a significantly faster turn-around-time as it requires just 75 minutes to conduct the test without any cross reactivity with other diseases. The kit has a shelf life of 18 months.
vimarsana © 2020. All Rights Reserved.